Active, not recruiting
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
NCT07471880
- Conditions
- Bone Diseases, Femur Head Necrosis, Legg-Calve-Perthes Disease, +6 more
- Locations
-
- ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. Zhongshan, Guangdong, China